The following information, which has been conveyed to our Company by our shareholder Lightyear Healthcare BV (|||Lightyear|||) and Mr. Muharrem Usta, is hereby presented to your attention:
A sale is planned for the B Class shares of MLP Sağlık Hizmetleri A.Ş. (|||MPARK|||) owned by Lightyear, with a nominal value of TL 28,703,174 and representing 15.03% of the issued capital of the company, through an accelerated bookbuilding process to various institutional investors located abroad and in Turkey. All updates regarding this transaction (such as the launch of the sale, pricing, and settlement) will be disclosed to the public in accordance with the relevant legislation.
Simultaneously with the aforementioned accelerated bookbuilding process, A Class shares corresponding to approximately 11% to 13% of MPARK`s issued capital and held by Lightyear will be purchased by Mr. Muharrem Usta or by FOM Grup Mimarlık İnşaat ve Ticaret A.Ş., which is under his control. The acquisition is fully financed. The per-share transfer price applicable to this transaction will be equal to the per-share sale price determined under the concurrently conducted accelerated bookbuilding process. The final number of shares to be transferred will be finalized concurrently with the determination of the sale price and will be disclosed to the public accordingly.
Following the completion of the two transactions mentioned above, the parties have agreed that the remaining A Class MPARK shares held by Lightyear will also be purchased by Mr. Muharrem Usta or FOM Grup Mimarlık İnşaat ve Ticaret A.Ş., under his control, by no later than September 30, 2026.
Upon completion of the transactions, the shareholding amounts of Lightyear and Mr. Muharrem Usta in MPARK will be announced through material event disclosures.
Mr. Muharrem Usta will continue to serve as Chairman of the Board and CEO of the Company and will work to maintain and further develop the Company`s current investment strategy with a growth-oriented approach.
